Meet with our product experts in one-on-one virtual sessions
Set Up a Meeting
Finished Dosage Forms - Product List:
Download Brochure
Dr. Reddy’s Laboratories is a leading API supplier, with a presence in over 80 countries and a portfolio of 200+ ANDA filings and approved dossiers. Our offering goes beyond APIs and our global customers have access to high-quality dossiers and finished dosage forms.
| Therapy Area | Product Name | Dosage Form | EU Approval Status | US Approval Status |
|---|---|---|---|---|
| Oncology | Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/ml) and 50 mg/25 ml (2 mg/ml) Single-dose Vials | Injection | Under review | Approved |
| Oncology | Imatinib Mesylate Tablets 100/400 mg | NA | Approved | |
| Oncology | Imatinib Mesylate Capsules 50/100/400 mg | Approved | NA | |
| Oncology | Docetaxel Injection Concentrate and 80 mg/4 ml | Injection | Approved | Approved |
| Oncology | Bendamustine HCl Concentrate for Solution for Infusion 180 mg 4 ml | Approved | NA | |
| Immuno Suppressant | Fingolimod 0.5mg | Approved | Approved | |
| Oncology | Bendamustine Hydrochloride Injection 25 mg/Vial and 100 mg/Vial | Injection | NA | Tentative Approved |
| Oncology | Capecitabine Tablets 500 mg | Approved | Approved | |
| Oncology | Capecitabine Tablets 150 mg | Oral | NA | Approved |
| Oncology | Fulvestrant Injection 250 mg/5 ml (50 mg/ml) | Injection | Approved | Approved |
| Oncology | Everolimus 2.5mg, 5mg & 10mg | Approved | NA | |
| Oncology | Dasatinib 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, 140 mg Film tablet | Under review | Tentative Approved | |
| Oncology | Bortezomib For Injection 3.5 mg/vial | Injection | Approved | Approved |
| Oncology | Decitabine for Injection 50 mglVial | Injection | NA | Approved |
| Oncology | Azacitidine for Inj 100 mg/vial | Injection | Approved | Approved |
| Oncology | Lenalidomide Capsules 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg | NA | Approved (2.5, 20 mg) Tentative approved (Other SKUs) | |
| Oncology | Pemetrexed, 100 mg, 500 mg, powder for concentrate for solution for infusion (Di Sodium Amorphous) | Approved | Tentative Approved | |
| Oncology | Pemetrexed for Injection 100 mg/Vial, 500 mg/Vial, 1g/vial | Injection | NA | Tentative Approved |
| Oncology | Pomalidomide Capsules 1mg, 2mg, 3mg and 4mg | NA | Tentative Approved | |
| Oncology | Carfilzomib for injection 60mg/vial | Injection | NA | Approved |
| Oncology | Palbociclib Capsules, 75 mg, 100 mg and 125 mg | NA | Tentative Approved | |
| Oncology | Abiraterone Acetate Tablets 250 mg | NA | Approved | |
| Oncology | Melphalan Hydrochloride for Injection, 50 mg Single-Dose Vial | Injection | NA | Approved |
| Oncology | Cabazitaxel Injection 60 mg/1.5 ml | Injection | Approved | Approved |
| Oncology | Sunitinib Malate | Oral | NA | Approved |
| Immuno Suppressant | Tacrolimus Capsules, 0.5 mg, 1 mg and 5 mg | NA | Approved | |
| Immuno Suppressant | Sirolimus 1 mg and 2 mg | NA | Approved |
Our VisionTo reach 1.5 Billion People Across The Globe
Dr. Reddy’s API:
Dr. Reddy’s supplies high-quality APIs to leading formulation manufacturers across the world, enabling them to develop affordable medicines for patients worldwide. We are the preferred API partner to pharma companies across the US, Europe, Latin America, Japan, China, Korea and emerging markets.
B2B Formulations:
To enable access to medicines in countries where we are not directly present, we supply the finished products to our partners for them to distribute and commercialize. We offer market specific products and dossiers which meets the local requirements in securing the marketing authorization followed by commercialization. The products and dossiers can be customized as per country requirements.
Our Business ModelActivities at partner end
-
Pre-formulation SupplyAnalytical Method transfer
-
Formulation SupplyFiling
-
Pre-formulation SupplyConfirmatory Batch
-
Formulation SupplyApproval
-
Pre-formulation SupplyExhibit batches
-
Pre-formulation SupplyStability Studies
-
Pre-formulation SupplyBio study
-
Pre-formulation SupplyFiling
-
Pre-formulation SupplyApproval
In addition to formulation, pre-formulation supplies and technology transfer, we also focus on increasing our presence across:
Global Presence
